55I LLC’s CME Group CME Stock Holding History

55I LLC’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$507K	Buy	2,863 +1,159	+68%	+$229K	0.01%	378
2022 Q2	$349K	Buy	+1,704	New	+$361K	0.01%	412

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

55I LLC's CME Position: Q3 2022 in Review

55I LLC increased its CME Group (CME) stake by 68% in Q3 2022, buying an estimated $229K and bringing the position to 2,863 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #378.

55I LLC first reported a position in CME in Q2 2022 and has held it in 2 quarters since. 1,145 funds tracked by Wall St. Rank hold CME as of Q3 2022.

55I LLC held 2,863 shares of CME Group worth $507K as of Q3 2022.
55I LLC bought 1,159 CME Group shares in Q3 2022, an estimated $229K.
CME Group made up 0.01% of 55I LLC's portfolio in Q3 2022, its #378 holding.
55I LLC first reported a position in CME Group in Q2 2022 and has held it in 2 quarters since.
1,145 funds tracked by Wall St. Rank held CME Group as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.